Composition, pharmaceutical composition, use of a stable topical composition comprising a nanoemulsion and of at least one antileishmanial compound, and method for the treatment of cutaneous leishmaniasis
US-2024016826-A1 · Jan 18, 2024 · US
Absorbable crystalline copolyester-based bioactive hydroforming luminal liner compositions
US9050366B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9050366-B2 |
| Application number | US-201313754110-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jan 30, 2013 |
| Priority date | Apr 3, 2009 |
| Publication date | Jun 9, 2015 |
| Grant date | Jun 9, 2015 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
Bioactive, hydroforming luminal liner compositions are formed of high molecular weight crystalline, absorbable copolyesters dissolved in a liquid derivative of a polyether glycol that undergoes transformation into a tissue-adhering, resilient interior cover or liner for the controlled release of its bioactive payload at clinically compromised conduits in humans as in the case of bacteria- and yeast-infected vaginal canals, esophagi, and arteries following angioplasty.
First claim
Opening claim text (preview).
What is claimed is: 1. A bioactive, hydroforming, luminal liner composition comprising at least one crystalline, absorbable copolyester having a heat of fusion of at least 10 J/g and a molecular weight of greater than of 20 kDa; at least one liquid derivative of a polyether glycol; and at least one bioactive agent comprising an antifungal agent selected from the group consisting of ketoconazole, miconazole, voriconazole, and fluconazole. 2. A bioactive, hydrofor…
Assignees
Inventors
Classifications
Human Necessities · mapped topic
- A61K31/7036Primary
Human Necessities · mapped topic
Human Necessities · mapped topic
Human Necessities · mapped topic
Operations & Transport · mapped topic
Patent family
Related publications grouped by family.
External sources
Next steps
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US9050366B2 cover?
- Bioactive, hydroforming luminal liner compositions are formed of high molecular weight crystalline, absorbable copolyesters dissolved in a liquid derivative of a polyether glycol that undergoes transformation into a tissue-adhering, resilient interior cover or liner for the controlled release of its bioactive payload at clinically compromised conduits in humans as in the case of bacteria- and y…
- Who is the assignee on this patent?
- Poly Med Inc
- What technology area does this patent fall under?
- Primary CPC classification A61K31/7036. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Tue Jun 09 2015 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).